Hybrid Closed-loop Insulin Delivery System in Perioperative Diabetic Patients: an Open-label, Randomized Controlled Trial - Trial NCT06295289
Access comprehensive clinical trial information for NCT06295289 through Pure Global AI's free database. This phase not specified trial is sponsored by Huazhong University of Science and Technology and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Huazhong University of Science and Technology
Timeline & Enrollment
N/A
Oct 16, 2023
Dec 04, 2024
Primary Outcome
TIR
Summary
Perioperative management of glucose levels remains challenging. The purpose of the study is
 to compare the hybrid closed-loop insulin delivery system with the standard insulin therapy (
 insulin pump with CGM, insulin dose controlled by physicians) in controlling glucose levels
 among patients in the perioperative period.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06295289
Device Trial